COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03540745
Recruitment Status : Active, not recruiting
First Posted : May 30, 2018
Last Update Posted : October 11, 2018
Carrier Clinic
Information provided by (Responsible Party):
Michael A. Grandner, University of Arizona

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : November 2019